Researchers at the University of Basel have made a groundbreaking discovery that reverts cancer cells back into normal cells. To find new ways to treat triple-negative breast cancer, researchers have differentiated cancer cells to convert them into less harmful cells that no longer divide.
In another study published in the journal Pancreas, researchers found that the introduction of a protein called E47 coaxes pancreatic cancer cells to revert toward normal cells. The researchers found that E47 binds to specific DNA sequences, which controls genes that are involved in growth and differentiation.
These discoveries could lead to the development of new treatments for cancer and provide hope for patients with this devastating disease.
